YTD Mar23 revenues of $81m so only ~$14-16m in revenues in 4Q23 which means US was pretty weak (if we assume Aus brought in ~5m).
The positive is that they have cut out costs (I'm hoping a bit more than $2m in the US as costs have increased significantly post Guildlink), and that pipeline in healthier than last year given what they did in 1H23......I'm hoping that vaccine awareness program which seemed to help revenues in 1H23 can be made up with their rollout of more pharmacies.
20m in cash at the end of Mar23.......with revenues pretty muted in 4Q23 I'm hoping they have enough cash in the tank before the cahflow starts up again in 1Q24.
Ann: MDR undertakes strategic review, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.020(5.13%) |
Mkt cap ! $226.0M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 41.5¢ | 39.0¢ | $240.8K | 603.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 7692 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MDR (ASX) Chart |